Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2013-07-09 16:07:47 UTC |
---|
Update Date | 2019-07-23 07:15:24 UTC |
---|
HMDB ID | HMDB0060928 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Buprenorphine glucuronide |
---|
Description | Buprenorphine glucuronide belongs to the class of organic compounds known as phenolic glycosides. These are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose. Based on a literature review a significant number of articles have been published on Buprenorphine glucuronide. |
---|
Structure | [H][C@]12CC3=C4C(O[C@@H]5[C@@]4(CCN1CC1CC1)[C@@]21CC[C@@]5(OC)[C@H](C1)[C@@](C)(O)C(C)(C)C)=C(O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O)C=C3 InChI=1S/C35H49NO10/c1-31(2,3)32(4,42)20-15-33-10-11-35(20,43-5)30-34(33)12-13-36(16-17-6-7-17)21(33)14-18-8-9-19(26(46-30)22(18)34)44-29-25(39)23(37)24(38)27(45-29)28(40)41/h8-9,17,20-21,23-25,27,29-30,37-39,42H,6-7,10-16H2,1-5H3,(H,40,41)/t20-,21-,23+,24+,25-,27+,29-,30-,32-,33-,34+,35-/m1/s1 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C35H49NO10 |
---|
Average Molecular Weight | 643.7643 |
---|
Monoisotopic Molecular Weight | 643.335646793 |
---|
IUPAC Name | (2S,3S,4S,5R,6S)-6-{[(1S,2R,6S,14R,15R,16R)-3-(cyclopropylmethyl)-16-[(2R)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-3-azahexacyclo[13.2.2.1²,⁸.0¹,⁶.0⁶,¹⁴.0⁷,¹²]icosa-7,9,11-trien-11-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid |
---|
Traditional Name | (2S,3S,4S,5R,6S)-6-{[(1S,2R,6S,14R,15R,16R)-3-(cyclopropylmethyl)-16-[(2R)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-3-azahexacyclo[13.2.2.1²,⁸.0¹,⁶.0⁶,¹⁴.0⁷,¹²]icosa-7,9,11-trien-11-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H][C@]12CC3=C4C(O[C@@H]5[C@@]4(CCN1CC1CC1)[C@@]21CC[C@@]5(OC)[C@H](C1)[C@@](C)(O)C(C)(C)C)=C(O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C(O)=O)C=C3 |
---|
InChI Identifier | InChI=1S/C35H49NO10/c1-31(2,3)32(4,42)20-15-33-10-11-35(20,43-5)30-34(33)12-13-36(16-17-6-7-17)21(33)14-18-8-9-19(26(46-30)22(18)34)44-29-25(39)23(37)24(38)27(45-29)28(40)41/h8-9,17,20-21,23-25,27,29-30,37-39,42H,6-7,10-16H2,1-5H3,(H,40,41)/t20-,21-,23+,24+,25-,27+,29-,30-,32-,33-,34+,35-/m1/s1 |
---|
InChI Key | CZULHKGIAJASAA-RONBUCGTSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenolic glycosides. These are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic oxygen compounds |
---|
Class | Organooxygen compounds |
---|
Sub Class | Carbohydrates and carbohydrate conjugates |
---|
Direct Parent | Phenolic glycosides |
---|
Alternative Parents | |
---|
Substituents | - Phenolic glycoside
- Fatty acyl glycoside
- Fatty acyl glycoside of mono- or disaccharide
- 1-o-glucuronide
- O-glucuronide
- Phenanthrene
- Glucuronic acid or derivatives
- Alkyl glycoside
- Hexose monosaccharide
- O-glycosyl compound
- Azaspirodecane
- Tetralin
- Coumaran
- Aralkylamine
- Alkyl aryl ether
- Beta-hydroxy acid
- Benzenoid
- Fatty acyl
- Monosaccharide
- Oxane
- Hydroxy acid
- Piperidine
- Pyran
- Tertiary alcohol
- Tertiary aliphatic amine
- Amino acid
- Tertiary amine
- Amino acid or derivatives
- Secondary alcohol
- Acetal
- Oxacycle
- Carboxylic acid derivative
- Carboxylic acid
- Dialkyl ether
- Ether
- Azacycle
- Organoheterocyclic compound
- Polyol
- Monocarboxylic acid or derivatives
- Organic nitrogen compound
- Organopnictogen compound
- Amine
- Organic oxide
- Hydrocarbon derivative
- Alcohol
- Organonitrogen compound
- Carbonyl group
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Buprenorphine glucuronide,1TMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4522.9 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,1TMS,isomer #2 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4544.5 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,1TMS,isomer #3 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4543.3 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,1TMS,isomer #4 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]5O[Si](C)(C)C)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4545.4 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,1TMS,isomer #5 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4492.0 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,2TMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4436.2 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,2TMS,isomer #10 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]5O[Si](C)(C)C)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4441.3 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,2TMS,isomer #2 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4473.9 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,2TMS,isomer #3 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4476.1 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,2TMS,isomer #4 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]5O[Si](C)(C)C)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4468.7 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,2TMS,isomer #5 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4449.6 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,2TMS,isomer #6 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4471.8 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,2TMS,isomer #7 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]5O[Si](C)(C)C)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4476.1 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,2TMS,isomer #8 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4436.2 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,2TMS,isomer #9 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]5O[Si](C)(C)C)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4464.4 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,3TMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4428.8 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,3TMS,isomer #10 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]5O[Si](C)(C)C)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4390.2 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,3TMS,isomer #2 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4419.4 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,3TMS,isomer #3 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O)[C@H](O)[C@H]5O[Si](C)(C)C)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4417.3 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,3TMS,isomer #4 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4433.9 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,3TMS,isomer #5 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]5O[Si](C)(C)C)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4436.6 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,3TMS,isomer #6 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O[Si](C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C)[C@H]5O[Si](C)(C)C)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4423.2 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,3TMS,isomer #7 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4397.6 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,3TMS,isomer #8 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H](O)[C@H]5O[Si](C)(C)C)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4405.6 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,3TMS,isomer #9 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@H]5O[Si](C)(C)C)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4401.9 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,1TBDMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O[Si](C)(C)C(C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4760.9 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,1TBDMS,isomer #2 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4747.8 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,1TBDMS,isomer #3 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4746.7 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,1TBDMS,isomer #4 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]5O[Si](C)(C)C(C)(C)C)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4754.1 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,1TBDMS,isomer #5 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4722.7 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,2TBDMS,isomer #1 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O[Si](C)(C)C(C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4873.0 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,2TBDMS,isomer #10 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O)[C@H]5O[Si](C)(C)C(C)(C)C)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4859.1 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,2TBDMS,isomer #2 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O[Si](C)(C)C(C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4908.1 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,2TBDMS,isomer #3 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O[Si](C)(C)C(C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4905.0 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,2TBDMS,isomer #4 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O[Si](C)(C)C(C)(C)C)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]5O[Si](C)(C)C(C)(C)C)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4910.4 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,2TBDMS,isomer #5 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4861.4 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,2TBDMS,isomer #6 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4859.0 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,2TBDMS,isomer #7 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](O)[C@H]5O[Si](C)(C)C(C)(C)C)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4864.3 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,2TBDMS,isomer #8 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]5O)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4838.3 | Semi standard non polar | 33892256 | Buprenorphine glucuronide,2TBDMS,isomer #9 | CO[C@]12CC[C@@]3(C[C@@H]1[C@@](C)(O)C(C)(C)C)[C@H]1CC4=CC=C(O[C@@H]5O[C@H](C(=O)O)[C@@H](O)[C@H](O[Si](C)(C)C(C)(C)C)[C@H]5O[Si](C)(C)C(C)(C)C)C5=C4[C@@]3(CCN1CC1CC1)[C@H]2O5 | 4854.2 | Semi standard non polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a6u-9100032000-61ed1b62d8e6f9f22cff | 2017-09-20 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_1_5) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_2_6) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_2_7) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_2_8) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_2_9) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_2_10) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_3_1) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_3_2) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_3_3) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_3_4) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_3_5) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_3_6) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_3_7) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_3_8) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Buprenorphine glucuronide GC-MS (TMS_3_9) - 70eV, Positive | Not Available | 2021-10-17 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buprenorphine glucuronide 10V, Positive-QTOF | splash10-0kxr-3100809000-31127829533f85921935 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buprenorphine glucuronide 20V, Positive-QTOF | splash10-0pvi-4100901000-2617dbef663385d1d573 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buprenorphine glucuronide 40V, Positive-QTOF | splash10-0a4i-9100200000-8cce590a2c49a58615b3 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buprenorphine glucuronide 10V, Negative-QTOF | splash10-00kg-2400659000-f96b4f477e75cf8b5879 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buprenorphine glucuronide 20V, Negative-QTOF | splash10-014j-2200932000-540e32bd0497a41a49a0 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buprenorphine glucuronide 40V, Negative-QTOF | splash10-02t9-4202900000-981ad3c6d8e785b4b853 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buprenorphine glucuronide 10V, Positive-QTOF | splash10-0006-0000009000-ad37a778bc5d3af5526a | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buprenorphine glucuronide 20V, Positive-QTOF | splash10-002f-0000139000-b1b057862ae685876ef4 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buprenorphine glucuronide 40V, Positive-QTOF | splash10-0006-3100229000-931e3f76d03c6b5406fa | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buprenorphine glucuronide 10V, Negative-QTOF | splash10-0006-0000009000-79689f683b56b0ed360b | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buprenorphine glucuronide 20V, Negative-QTOF | splash10-00kf-4100769000-da29fc2f3bf51a6ab85c | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Buprenorphine glucuronide 40V, Negative-QTOF | splash10-0aor-9100430000-6c46fa27b4013d362afb | 2021-10-12 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-24 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Normal | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 30778609 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 131769995 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 184032 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | Not Available |
---|